CLN8 anticorps (C-Term)
-
- Antigène Voir toutes CLN8 Anticorps
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Épitope
- AA 250-280, C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLN8 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- CLN8, CT (CLN8, C8orf61, Protein CLN8)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogène
- CLN8 antibody is generated from rabbits immunized with a KLH conjugated synthetic between 250-280 amino acids selected from the C-terminal region of human CLN8.
- Isotype
- IgG
- Top Product
- Discover our top product CLN8 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
- Autre désignation
- CLN8 (CLN8 Produits)
- Synonymes
- anticorps mnd, anticorps C8orf61, anticorps EPMR, anticorps CLN8, transmembrane ER and ERGIC protein, anticorps ceroid-lipofuscinosis, neuronal 8, anticorps CLN8, anticorps Cln8
- NCBI Accession
- NP_061764
- UniProt
- Q9UBY8
- Pathways
- Regulation of Cell Size, Dicarboxylic Acid Transport
-